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Summary and Conclusions
Consumers are increasingly demanding food that is free from pathogens,
but with less  preservatives and additives. As a response to  these
conflicting demands, current trends in the food industry include minimal
processing, and the investigation of alternative inhibitors for use in foods. 
Additionally, the manufacture of an increasing range of novel foods, and
the inclusion of non-dairy ingredients into dairy products, and vice versa,
poses additional dangers with respect to safety. Furthermore, the dramatic
increase in incidence of food-borne illness internationally, as a result of
contamination with food-borne pathogens such as Listeria
monocytogenes, is a cause of considerable consumer concern.  
Bacteriocins are inhibitory peptides produced by a number of Lactic Acid
Bacteria which are capable of killing other bacteria.  These natural
inhibitors have widespread applications in the preservation of foods, since
they can kill a number of pathogenic and spoilage bacteria.
The broad spectrum bacteriocin Lacticin 3147 (discovered in a previous
project and patented - see DPRC No. 3) is produced by Lactococcus lactis
subsp. lactis DPC3147, a food-grade strain, similar to strains used for
commercial cheese manufacture.  Lacticin 3147 is effective in the
inhibition of all Gram positive bacteria tested including the food
pathogens Listeria monocytogenes and Staphylococcus aureus and food
spoilage bacteria such as Clostridia and Bacillus species.
As part of this project the bacteriocin Lacticin 3147 was assessed as a food
preservative for improving food safety via inhibition of pathogenic
organisms.  
Thus the project plan followed a "twin-track" approach to assessing and
controlling the food safety aspects of Irish food.
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The first of these was designed to investigate the current safety status of
Irish dairy products. 
The second approach involved an attempt to exploit natural antimicrobial
substances, including Lacticin 3147, to protect foods from pathogenic
bacteria.
Main Conclusions and Achievements
Assessment of Foodborne Pathogens:
* A representative sample of commercially available smear-ripened,
surface-ripened  and unpasteurised milk cheeses, were found to be free of
E. coli O157:H7, Listeria monocytogenes and Salmonella spp.  The dairy
products investigated are those considered most likely to harbour these
dangerous pathogens.
* It was demonstrated that both Listeria monocytogenes and E. coli
O157:H7, if present, could grow rapidly during cheese-making, and
subsequently survive in significant numbers during ripening which could
pose a serious threat to consumers.
Because of its pathogenicity and low infective dose, the presence, even in
low numbers, of E. coli O157:H7 in particular, in raw milk destined for
cheese manufacture, is a particular concern.
These studies also highlighted the necessity for representative sampling of
both the rind and core of the cheese to ensure accurate pathogen
detection.
* Highly sensitive and specific methods (PCR) were adapted and
successfully used to trace the origin  of Listeria monocytogenes in dairy
processing plants, and to detect E. coli O157:H7 and Listeria
monocytogenes in dairy products.
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In cheese, E. coli O157:H7 can now be detected at an extremely low level
of 1/g (compared to 103 cfu/g by the current method) facilitating improved
detection of the pathogen as well as the study of microbial survival kinetics
at very low cell numbers.
A rapid screening procedure was also developed for detection of inhibitors
to pathogens.
* Acidity (low pH) and salt are used traditionally for food preservation.
However studies of E. coli O157:H7 show that exposure to (relatively
high) pH 5.5 for one hour can enhance subsequent survival of the
organism at pH 3.0 - normally considered lethal for the pathogen.
Similarly it was shown that in some circumstances sodium chloride may
in fact promote both the recovery and growth of stressed bacterial cells.
Cells grown in milk were more stress tolerant than those grown in
laboratory media.
Control of Foodborne Pathogens:
* Following optimisation of Lacticin 3147 production in reconstituted
demineralised whey powder, a pilot scale food grade spray-dried Lacticin
3147 powder preparation was manufactured.  Bacteriocin activity
remained constant throughout manufacture, indicating that no loss in
activity occurred during processing.
Lactococcus lactis DPC3147 (the Lacticin 3147 producing strain) was
immobilised in double-layered calcium alginate beads providing an
effective, stable and long term method of producing the bacteriocin.
*  Lacticin 3147 was successfully immobilised on packaging film where it
reduced counts of Listeria and Staphylococcus aureus on the surface of
ham and cheese.
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* The effectiveness of Lacticin 3147 as an inhibitor of both spoilage and
pathogenic bacteria was demonstrated in a wide variety of food systems
including infant food formula, powdered soup, cottage cheese, natural
yogurt and fresh pork sausage.
* Lacticin 3147 in combination with high hydrostatic pressure resulted in
greater pathogen inhibition than either treatment alone.    
* Lacticin 3147 was found to inhibit a range of clinically important human
(gram positive) pathogens including some antibiotic resistant strains.
Research and Results
Section 1: 
ASSESSMENT OF FOODBORNE PATHOGENS
Screening of Dairy Products for the Presence of Pathogenic
Microorganisms
In order to reassure consumers of the safety of Irish dairy products and to
pre-empt problems it is important to determine if food pathogens could
be detected in dairy products.  Some of the higher risk dairy products
include raw (unpasteurised) milk cheese, smear-ripened cheese and
surface-ripened cheese.  On two independent occasions 30 cheeses from
these categories were obtained.  The samples were tested for the presence
of E. coli O157, Listeria monocytogenes and Salmonella spp. using the
EiaFoss rapid detector, which is an immunologically based method that
was shown to be capable of detecting 1 cell/50 g of cheese.
None of the three food pathogens were detected in any of the cheeses.
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Pathogen Survival in Cheese
Although the process of cheese ripening represents an environment
unsuitable for survival of E. coli O157:H7 and Listeria monocytogenes,
the process of manufacture can encourage growth of these pathogens.
We developed a laboratory scale process for the manufacture and
ripening of a semi-soft smear-ripened cheese made from raw milk to
study the growth and death kinetics of E. coli O157:H7 and Listeria
monocytogenes during the different stages of processing.  The cheesemilk
was inoculated with 33 ± 4 cfu/ml E. coli O157:H7 or 5 x 103 cfu/ml
Listeria monocytogenes.  In both cases pathogen growth during
manufacture was sufficient to allow considerable survival during ripening.
Fig. 1: The death kinetics of Listeria monocytogenes CI 2 in the rind (exterior) (   ), and core
(interior) (  ) of the cheese during ripening.  Values are the average of duplicate vats. The
initial increase in cell numbers represents growth during manufacture.
Death of Listeria monocytogenes occurred in the core (interior) of the
cheese, but even after 60 days a considerable number survived (Fig. 1).
Death occurred at a faster rate on the rind (exterior), possibly due to
competitive inhibition by the surface smear flora.
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The results emphasise the importance of representative product sampling,
including rind and core, for detection and estimation of pathogen
numbers in cheese.
Fig. 2: The death kinetices of E. coli O157:H7 in the rind (  ), and core (  ) of the cheese
during ripening.  Values are the average of quadruplicate vats.  The initial increase represents
growth during manufacture.
Growth of E. coli O157:H7 occurred during manufacture of the cheese.
During ripening the rate of death was greater in the core of the cheese
than on the rind (Fig. 2). In both the rind and core of the cheese the
organism could be isolated after 70 days. 
Because of the low infective dose of this pathogen low numbers can pose
a threat to the consumer.
These results again indicate the necessity for proper sampling of the rind
and core of the cheese. They also indicate that the manufacturing
procedure encouraged substantial growth of E. coli O157:H7 to levels
that permitted survival during ripening and extended storage. 
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The presence of low numbers (33 cfu/ml) of E. coli O157:H7 in milk,
destined for raw milk cheese manufacture, could constitute a threat to the
consumer. 
Stress Responses in Pathogenic Microorganisms
Many bacteria can produce responses to a particular stress that enable
them to survive that stress. In addition, they can induce adaptive
tolerance responses (ATR), where exposure to a non-lethal stress can
induce responses that allow survival of a lethal stress. Some ATRs are
specific in that they only confer resistance to the stress used to induce
them. Others are global responses that confer cross resistance to other
stress factors.
During this project we examined the induction of ATR by E. coli
O157:H7.
We have shown that the induction of these responses can alter the death
kinetics of the organism (Fig. 3).
Induction of the ATR at pH 5.5 for 1 h can enhance survival at pH 3.0.
This increased tolerance to pH 3.0 was shown to be due to a change in
proton flux across the cell membrane. Using two dimensional
electrophoresis, it was possible to view the proteins of the cell membrane.
Differences in the membrane proteins of adapted and non-adapted cells
were observed.
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Fig. 3: The survival of E. coli O157:H7 (strain P1432) at pH 3.0, before (  ), and after (  )
adaptation at pH 5.0 for 1 h prior to challenge.  Prior to acid challenge cultures were grown
to mid-exponential phase (pH 7.0) at 30ºC. 
Expression of the protein (highlighted by arrow in Fig. 4 was also
considerably increased with induction by lactate and acetate, but not by
induction with heat. The level of this protein was quantified by using a
computer to measure the density of the protein spot in terms of the pixel
intensity.  Cross resistance to other acids, but not to heat, was conferred
with acid induction.  The rpoS related proteins are associated with the
stationary phase of bacterial growth and confer global stress resistance.
Increased expression of the protein was not seen in stationary phase cells,
suggesting that rpoS was not involved.  It was concluded that increased
expression of this protein is a specific response to acid and not a global
response.
Transposon mutagenesis is a method of interrupting gene expression by
randomly inserting an extra piece of DNA into a gene. Since the insertion
is random, a large number of isolates must be screened to find a strain
with the required gene interruption. Using this method a mutant of E. coli
that has an ATR gene interrupted and is, therefore, unable to induce an
ATR to HCl was isolated. This mutant will be used to identify the
interrupted gene and to study the role of ATR in different environments. 
Fig. 4: The membrane proteins of E. coli O157:H7 (acid adapted) as separated by two
dimensional gel electrophoresis.  One particular protein (shown by an arrow) showed almost
a 10-fold increase in expression when cells were adapted.
Sodium chloride was shown to increase the recovery and growth of E. coli
O157:H7 cells that were stressed with lactate (Table 1).  It is generally
accepted that sodium chloride is an additional stress factor when added to
food.  However, these results indicate that this may not always be the case,
as the sodium chloride may promote recovery and growth of stressed cells.
11
12
Table 1: The effect of different sodium chloride and lactate concentrations on the growth rate
of acid stressed cells of strain P1432 in broth at pH 5.0. 
Lactate Salt concentration %
% 0 4 5 6
0 0.79±0.03 1.21±0.11 1.32±0.05 1.32±0.09
0.5 0.65±0.02 1.20±0.13 1.06±0.09 1.08±0.03
1.0 0.61±0.01 1.59±0.39 1.12±0.06 1.28±0.04
1.5 NG1 1.22±0.06 0.94±0.04 1.22±0.29
NG1 -  no growth
Section 2: 
CONTROL OF FOODBORNE PATHOGENS
Screening for Bacteriocin-Producing Strains
A number of natural sources including raw milk, Kefir grains, dairy
products and the brewing environment were screened for producers of
inhibitory compounds.  A procedure was developed for the rapid
screening of dairy produce for the presence of inhibitory substances.  The
procedure enables the screening of a large number of samples in a short
length of time.  A number of potential inhibitors to both Listeria and E.
coli were identified (Fig. 5), in addition to Lactic Acid Bacteria capable of
inhibiting B. cereus. The inhibition of Listeria by Kefir fermentates could
be attributed to bacteriocin activity in a number of cases.  With regard to
the inhibition of E. coli, inhibition appears to be due perhaps to the
combination of acid and oxidative killing.
Fig. 5: The inhibitory effects of a number of potential bacteriocin producing strains isolated
from a Kefir fermentate. Zones of clearing indicate inhibitory activity.
As part of the above study, five hundred raw milk samples were screened
for bacteriocin producing bacteria.  Of these, 362 strains exhibited
antimicrobial activity.  Two bacteriocins, designated Lacticin 104 and
Lacticin 115, were subsequently identified which inhibited a wide range of
Gram positive bacteria including Listeria monocytogenes.  
Characterisation of Novel Inhibitory Activities
The two novel bacteriocins isolated during the screening of raw milk
samples are produced by L. lactis cultures. 
Evidence suggested that Lacticin 104 had a medium spectrum of
inhibition, capable of inhibiting Listeria and Staphylococcus strains.
Inhibitory activity was active over a wide pH and temperature range.
Inhibitory activity was purified by ammonium sulphate precipitation,
application to XAD beads, cation exchange chromatography and reverse
phase high pressure liquid chromatography.  This revealed that this strain
13
produces a bacteriocin identical to a well-characterised lactococcal
bacteriocin, namely Lacticin 481.  The genetic determinants for inhibitory
activity are located on a 60 kb conjugative plasmid.  The strain
demonstrates an unusual phenomenon in that it induces a leaky
phenotype (increased release of intracellular contents) in lactococci, a
property under investigation for enhancing starter cell lysis in cheese
making.  
Scale-up of Lacticin 3147 Production to Pilot Scale
A major portion of this project involved the production of the broad-
spectrum bacteriocin Lacticin 3147 for food applications.  For this reason
Lacticin 3147 production was optimised, by detailed modelling of culture
performance during pH controlled fermentation studies. 
Increased Lacticin 3147 activity could be obtained by maintaining the pH
of the growth medium constant at pH 6.5.  Levels of bacteriocin activity
reached 10,240 AU/ml in 10% reconstituted demineralised whey powder
when the pH of the growth medium was held constant at pH 6.5
compared to 640 AU/ml when no pH control was imposed (Fig. 6).
Following the optimisation of Lacticin 3147 production in reconstituted
demineralised whey powder, suitable spray drying conditions were
identified that had no adverse effect on Lacticin 3147 activity.  
A pilot scale spray-dried Lacticin 3147 powder preparation was
manufactured and bacteriocin activity remained constant throughout
manufacture, indicating that no loss in bacteriocin activity occurred during
processing.
In parallel with the fermentor studies outlined above, the application of
immobilised cell technology for bacteriocin production was also assessed.
The suitability of a number of natural polymers as immobilisation
supports for L. lactis DPC3147 (the Lacticin 3147 producer) revealed that
alginate was the most suitable.  
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L.lactis DPC3147 was immobilised on double layered calcium alginate
beads and bacteriocin production was detected after 3 h and had
stabilised after 24 h.  Bacteriocin production from the immobilised cells
remained constant for the duration of the experiment (180 h), compared
to production by free cells which had declined after 80 h.
Results of this study suggest that the immobilisation of L. lactis DPC3147
may offer a more stable and long-term means of producing Lacticin 3147. 
Effectiveness of a powdered Lacticin 3147 product for the
control of Gram positive spoilage and pathogenic
microorganisms.
The powdered Lacticin 3147 was assessed for the inhibition of food
spoilage and pathogenic microorganisms in a number of food systems
including infant food formula, powdered soup, cottage cheese and
natural yogurt. 
Powdered Lacticin 3147 was very effective in killing pathogens and
spoilage organisms in a number of different food systems investigated.
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Fig. 6: Lacticin 3147 fermentations in 10% demineralised whey with: (a) no pH control and
(b) pH controlled at 6.5.  More (and larger) zones of inhibition represent greater activity.
Starting cell numbers in each case were approximately 105 cell forming
units per gram or millilitre.  The main findings are summarised hereunder.
-  In the infant milk formulation the use of the Lacticin 3147 powder
resulted in greater than a 99% kill of L. monocytogenes Scott A within 3
h at 30ºC.
-  The effect of Lacticin 3147 powder on the inhibition of L.
monocytogenes Scott A in natural yogurt demonstrated that greater than
98.3% of the culture was killed within 5 min at 30ºC and within 60 min
no viable cells remained. 
-  In the case of Cottage cheese 40% of the L. monocytogenes Scott A
population was killed within 5 min at 30ºC and within 160 min only 14%
of the population remained viable (Fig. 7). 
-  The effect of a range of concentrations of Lacticin 3147 in powdered
soup against B. cereus at 30ºC, demonstrated that following 24 h
incubation greater than a 99.9% kill was observed.
- A similar study was carried out to determine the effect of various
concentrations of Lacticin 3147 powder on the survival of L.
monocytogenes Scott A in powdered soup.  Interestingly the effect on
Listeria was not as marked as that observed for the inhibition of B. cereus.
-  A study was also performed to determine the effect of Lacticin 3147
powder on Bacillus spores.  A spore preparation exposed to Lacticin 3147
demonstrated that while the Lacticin 3147 powder does limit the
germination of spores, no killing effect was observed.
These results suggest that this bio-active Lacticin 3147 food ingredient
may find applications in many different foods, including those with pH
close to neutrality.
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Lacticin 3147 as a Preservative in Fermented Sausage
Lacticin 3147 has been investigated as a preservative in fermented
sausage.  The bacteriocin producing transconjugant strain L. lactis
DPC4275 and the non-producing parent strain DPC4268 are sensitive to
high levels (100 ppm) of sodium nitrite.  As levels of nitrite were
increased, starter growth and rates of acidification of the fermented
sausage were reduced.  An inverse relationship between bacteriocin
activity and nitrite concentration existed.  The inclusion of a culture pre-
enrichment step prior to inoculation into the meat mix enhanced
strain performance resulting in higher numbers of recoverable
starter cells.  In addition, both starter growth and rates of
acidification were enhanced with the addition of manganese or
magnesium, particularly when both manganese and magnesium
were combined. 
Hence, Lacticin 3147 cultures may be suitable for fermented
sausage manufacture.
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Fig. 7: (a) the Lacticin 3147 powder product, and (b) inhibition of Listeria monocytogenes
Scott A in Cottage cheese using the Lacticin 3147 powder.
Immobilised Lacticin 3147 on packaging film.
Both nisin (a commercial bacteriocin preparation) and Lacticin
3147 produced effective stable bioactive packaging material.
When applied to the surface of ham and cheese slices artificially
inoculated with L. innocua and S. aureus and stored at refrigeration 
temperatures under modified atmosphere packaging (MAP),
bioactive inserts reduced the recoverable population in both cases.
In addition, there was a positive inhibition observed in total aerobic
plate counts and lactic acid bacteria for both the ham and cheese
product over the 24-day period.  Cheese stored under vacuum
packaging, in bioactive vacuum pouches also demonstrated
reductions in non-starter lactic acid bacteria, L. innocua and S.
aureus during the 84-day test period compared to the control
(Fig. 8).
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Fig. 8: The inhibitory effect of lacticin
(1) and nisin (2) immobilised on a
cellulose based packaging material.
Zones of clearing (dark rectangular
areas) demonstrate inhibitory activity.
Controls on the left.
Lacticin 3147 in combination with High Hydrostatic
Pressure
The use of hydrostatic pressure and Lacticin 3147 treatments were
evaluated in milk and whey with a view to combining both
treatments for improving the quality of minimally processed dairy
foods.  The system was evaluated using two foodborne pathogens:
Staphylococcus aureus ATCC6538 and Listeria innocua DPC1770.
Trials against Staph. aureus ATCC6538 were performed using
concentrated Lacticin 3147 prepared from culture supernatant.  
Results demonstrated greater than an additive effect when both
treatments were used in combination (Fig. 9), for example, the
combination of 250 MPa (2.2 log reduction) and Lacticin 3147
(1 log reduction) resulted in more than 6 logs of kill of L. innocua.  
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Fig. 9: The effect of high hydrostatic pressure and Lacticin 3147 (alone and in
combination) on the viability of L. innocua DPC1770.
Similar results were obtained when a foodgrade powdered form of
Lacticin 3147 (developed from a spray-dried fermentation of
reconstituted demineralised whey powder) was evaluated for the
inactivation of L. innocua DPC1770.  Furthermore, it was
observed that treatment of Lacticin 3147 preparations with
pressures greater than 400 MPa yielded an increase in bacteriocin
activity (equivalent to a doubling of activity).
These results indicate that a combination of high pressure and
Lacticin 3147 may have potential for improving the quality of
minimally processed foods at lower hydrostatic pressure levels
Suitability of Lacticin 3147 for treatment of clinically important
Gram positive human pathogens.
The application of Lacticin 3147 for biomedical uses was investigated. 
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Fig. 10: The bactericidal effect of Lacticin 3147 (20,000 AU/ml) on the viability of (a)
methycillin resistant Staphylococcus aureus and (b) Streptococcus mutans.
Lacticin 3147 was found to inhibit a range of clinically important Gram
positive pathogens (Fig. 10) including methicillan resistant Staphylococcus
aureus (MRSA), vancomycin resistant Enterococci (VRE), penicillin
resistant Pneumococcus (PRP), Propionibacterium and Streptococcus
mutans.  
Further studies and trials are required to assess its potential as an
alternative therapeutic compound in serum and topical creams.
Patents
An anti-microbial effective against Gram positive pathogens:  IE Patent Application No.
980499; International Patent Application No. PCT/IE99/00057.
A spray-dried bacteriocin powder with anti-microbial activity: IE Patent Application No.
980500; International Patent Application No. PCT/IE99/00058.
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